Overview We are one of the worlds leading clinical contract research organizations, or CROs, by revenue, solely focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Our mission is to accelerate the global development of safe and effective medical therapeutics. We differentiate ourselves from our competitors by our disciplined operating model centered on providing full-service Phase I-IV clinical de...
Q2 FY2026 — expected 2026-07-17
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-10 | 2025-12-31 | 0001668397-26-000006 | EDGAR | 51K words |
| 2025-02-11 | 2024-12-31 | 0001668397-25-000017 | EDGAR | — |
| 2024-02-13 | 2023-12-31 | 0001668397-24-000013 | EDGAR | — |
| 2023-02-14 | 2022-12-31 | 0001668397-23-000008 | EDGAR | — |
| 2022-02-15 | 2021-12-31 | 0000950170-22-001280 | EDGAR | — |
| 2021-02-16 | 2020-12-31 | 0001564590-21-006072 | EDGAR | — |
| 2020-02-25 | 2019-12-31 | 0001564590-20-006385 | EDGAR | — |
| 2019-02-26 | 2018-12-31 | 0001564590-19-004451 | EDGAR | — |
| 2018-02-27 | 2017-12-31 | 0001564590-18-003500 | EDGAR | — |
| 2017-02-28 | 2016-12-31 | 0001564590-17-002839 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-10-23 | 2025-09-30 | 0001668397-25-000110 | EDGAR | 16K words |
| 2025-07-22 | 2025-06-30 | 0001668397-25-000087 | EDGAR | — |
| 2025-04-22 | 2025-03-31 | 0001668397-25-000059 | EDGAR | — |
| 2024-10-22 | 2024-09-30 | 0001668397-24-000168 | EDGAR | — |
| 2024-07-23 | 2024-06-30 | 0001668397-24-000143 | EDGAR | — |
| 2024-04-23 | 2024-03-31 | 0001668397-24-000091 | EDGAR | — |
| 2023-10-24 | 2023-09-30 | 0001668397-23-000048 | EDGAR | — |
| 2023-07-25 | 2023-06-30 | 0001668397-23-000043 | EDGAR | — |
| 2023-04-25 | 2023-03-31 | 0001668397-23-000033 | EDGAR | — |
| 2022-10-25 | 2022-09-30 | 0001668397-22-000009 | EDGAR | — |
| 2022-07-26 | 2022-06-30 | 0000950170-22-013080 | EDGAR | — |
| 2022-04-26 | 2022-03-31 | 0000950170-22-006201 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-09 | 0001668397-26-000004 | EDGAR | 5K words |
| 2025-10-22 | 0001668397-25-000108 | EDGAR | — |
| 2025-07-21 | 0001668397-25-000085 | EDGAR | — |
| 2025-05-16 | 0001193125-25-121801 | EDGAR | — |
| 2025-04-21 | 0001668397-25-000056 | EDGAR | — |
| 2025-03-31 | 0001668397-25-000037 | EDGAR | — |
| 2025-02-10 | 0001668397-25-000012 | EDGAR | — |
| 2024-10-21 | 0001668397-24-000165 | EDGAR | — |
| 2024-07-22 | 0001668397-24-000140 | EDGAR | — |
| 2024-07-03 | 0001193125-24-175077 | EDGAR | — |
139 total filings indexed. 107 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001668397 |
| Ticker | MEDP |
| Exchange | Nasdaq |
| SIC | 8731: Services-Commercial Physical & Biological Research |
| Incorporated | DE |
| Website | https://www.medpace.com |
| Listed | 2016-08-11 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report